Dr. Rizwan Attiq, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $410.16 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $169.99 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $58.13 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $48.31 | 2 | $0 (2023) |
| PFIZER INC. | $47.43 | 2 | $0 (2024) |
| ABBVIE INC. | $43.67 | 2 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.38 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.22 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $12.03 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $207.84 | 9 | Merck Sharp & Dohme LLC ($101.52) |
| 2023 | $104.99 | 4 | Merck Sharp & Dohme LLC ($56.68) |
| 2022 | $85.30 | 3 | AstraZeneca Pharmaceuticals LP ($58.13) |
| 2021 | $12.03 | 1 | GlaxoSmithKline, LLC. ($12.03) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/25/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/10/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/23/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/29/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: DIABETES | ||||||
| 04/12/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/24/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/07/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/30/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/25/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/14/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/19/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PROQUAD, VAXELIS | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: VACCINE | ||||||
| 09/14/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $58.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/20/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: PRIMARY CARE | ||||||
| 08/24/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 73 | 127 | $101,688 | $12,025 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 89 | $63,902 | $8,106 | 12.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 23 | 23 | $16,951 | $2,013 | 11.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $20,835 | $1,905 | 9.1% |
About Dr. Rizwan Attiq, MD
Dr. Rizwan Attiq, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2020. The National Provider Identifier (NPI) number assigned to this provider is 1316564750.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rizwan Attiq, MD has received a total of $410.16 in payments from pharmaceutical and medical device companies, with $207.84 received in 2024. These payments were reported across 17 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($410.16).
As a Medicare-enrolled provider, Attiq has provided services to 73 Medicare beneficiaries, totaling 127 services with total Medicare billing of $12,025. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Buffalo, NY
- Active Since 07/01/2020
- Last Updated 07/05/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1316564750
Products in Payments
- DIFICID (Drug) $158.20
- FARXIGA (Drug) $58.13
- XARELTO (Drug) $48.31
- VYNDAQEL (Drug) $47.43
- AVYCAZ (Drug) $23.11
- TEFLARO (Drug) $20.56
- NURTEC ODT (Drug) $15.38
- JARDIANCE (Drug) $15.22
- TRELEGY ELLIPTA (Drug) $12.03
- GARDASIL 9 (Biological) $11.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Buffalo
Sandra Sieminski, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $64,808
Carter Lindborg, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $40,328
Dr. Thomas Suchy, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $31,872
Paola Ghione, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $20,368
Vincent Croglio, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $15,454
Steven Green, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,842